Discovery of a Potent, Orally Bioavailable PI4KIII beta Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo.
Reuberson, J., Horsley, H., Franklin, R.J., Ford, D., Neuss, J., Brookings, D., Huang, Q., Vanderhoydonck, B., Gao, L.J., Jang, M.Y., Herdewijn, P., Ghawalkar, A., Fallah-Arani, F., Khan, A.R., Henshall, J., Jairaj, M., Malcolm, S., Ward, E., Shuttleworth, L., Lin, Y., Li, S., Louat, T., Waer, M., Herman, J., Payne, A., Ceska, T., Doyle, C., Pitt, W., Calmiano, M., Augustin, M., Steinbacher, S., Lammens, A., Allen, R.
J. Med. Chem.